The Royal Pharmaceutical Society (RPS) is recruiting for a new director for England after previous postholder Dr James Davies left the role at the end of last year.
Applicants for the £80,000-£85,000 director for England role must be a pharmacist, an RPS member, and have experience or knowledge of more than one sector in pharmacy and of health and social care systems in England.
The RPS will also recruit an acting director for Wales, as current director for Wales Elen Jones will move into a new 15-month fixed-term role.
Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist
As acting director of pharmacy for the RPS, Ms Jones will oversee the national directors in England, Wales and Scotland.
Elen Jones to oversee three national directors
Ms Jones has been overseeing professional leadership in both England and Wales since Dr Davies left his role.
In her new role, Ms Jones plans to focus on 'strengthening RPS advocacy for the profession'.
She will also support RPS chief executive Paul Bennett in 'strengthening collaboration with other professional bodies, specialist pharmacy groups and stakeholders as RPS transitions into the Royal College of Pharmacy', the RPS said.
And she will continue her current responsibilities for patient safety, guidance and heritage activities.
Related Article: ‘Streamlined’ DMS claims process to launch in July
Building foundations for the Royal College of Pharmacy
RPS chief executive Paul Bennett said the next 15 months would be 'very busy' for the RPS.
In particular, he highlighted the organisation's upcoming transition to become the Royal College of Pharmacy.
'I look forward to working with Elen as we focus on building the strategic and collaborative partnerships that will help secure the future foundations of the Royal College of Pharmacy for the benefit of the pharmacy ecosystem and the patients we serve,' he added.
Last month, around one quarter of RPS members voted for the organisation to become the Royal College of Pharmacy.
Related Article: RPS new director for England will build a ‘vibrant future’ for pharmacy
The 4,369 members in favour of the proposed changes represented 71.1% of those who voted, and the motion was passed.
The result was welcomed by pharmacy leaders including the four UK chief pharmaceutical officers.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.